000 01300 a2200361 4500
005 20250516163348.0
264 0 _c20140602
008 201406s 0 0 eng d
022 _a1533-4023
024 7 _a10.1097/FJC.0b013e31829f9e40
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKervinen, Marko
245 0 0 _aBilateral optic neuropathy and permanent loss of vision after treatment with amiodarone.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cOct 2013
300 _a394-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAmiodarone
_xadverse effects
650 0 4 _aAnti-Arrhythmia Agents
_xadverse effects
650 0 4 _aBlindness
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOptic Nerve Diseases
_xchemically induced
650 0 4 _aPapilledema
_xchemically induced
650 0 4 _aSeverity of Illness Index
650 0 4 _aTime Factors
650 0 4 _aVisual Fields
_xdrug effects
700 1 _aFalck, Aura
700 1 _aHurskainen, Merja
700 1 _aHautala, Nina
773 0 _tJournal of cardiovascular pharmacology
_gvol. 62
_gno. 4
_gp. 394-6
856 4 0 _uhttps://doi.org/10.1097/FJC.0b013e31829f9e40
_zAvailable from publisher's website
999 _c22981380
_d22981380